Figure 1.
Third-line treatment and non-relapse mortality without third-line treatment account for most failures after second-line treatment. (A) Survival, (B) FFS, and (C) causes of failure after second-line treatment of GVHD. Dotted lines above and below the Kaplan-Meier survival plot (solid line) show the pointwise 95% CI.

Third-line treatment and non-relapse mortality without third-line treatment account for most failures after second-line treatment. (A) Survival, (B) FFS, and (C) causes of failure after second-line treatment of GVHD. Dotted lines above and below the Kaplan-Meier survival plot (solid line) show the pointwise 95% CI.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal